Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients
- PMID: 27648143
- PMCID: PMC5009405
Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients
Abstract
Developing of personalized therapies for Triple Negative Breast Cancer (TNBC) requires a more detailed knowledge of its biology and a correct stratification of molecular subtypes. Androgen Receptor (AR) is expressed in a large part of TNBCs but its prognostic role in this Breast Cancer (BC) subtype is highly debated. In this study, we analyzed AR expression in a series of 238 TNBCs and correlated its expression with clinical-pathological features, survival, and metabolic profile. We showed a consistent association between AR expression and a better prognosis of TNBC patients, while its downregulation appeared strongly associated with diabetic disease. Since a recent prospective study reported a lower BC risk in diabetic women treated with drugs able to reduce circulating levels of glucose compared with non-diabetic woman, and in vitro studies showed that AR level are regulated directly by hyperglycemia, we speculate on the perspective of new integrated therapies for TNBC.
Keywords: Triple negative breast cancers; androgen receptor; diabetes.
Figures
Similar articles
-
Role of the androgen receptor in triple-negative breast cancer.Clin Adv Hematol Oncol. 2016 Mar;14(3):186-93. Clin Adv Hematol Oncol. 2016. PMID: 27058032 Free PMC article. Review.
-
Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer.Med Mol Morphol. 2016 Mar;49(1):11-21. doi: 10.1007/s00795-015-0109-0. Epub 2015 May 26. Med Mol Morphol. 2016. PMID: 26009308
-
Imaging features of triple-negative breast cancers according to androgen receptor status.Eur J Radiol. 2019 May;114:167-174. doi: 10.1016/j.ejrad.2019.03.017. Epub 2019 Mar 21. Eur J Radiol. 2019. PMID: 31005169 Free PMC article.
-
Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.BMC Cancer. 2019 Dec 30;19(1):1267. doi: 10.1186/s12885-019-6483-6. BMC Cancer. 2019. PMID: 31888566 Free PMC article.
-
A _targetable androgen receptor-positive breast cancer subtype hidden among the triple-negative cancers.Arch Pathol Lab Med. 2015 May;139(5):612-7. doi: 10.5858/arpa.2014-0122-RA. Epub 2014 Oct 13. Arch Pathol Lab Med. 2015. PMID: 25310144 Review.
Cited by
-
Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer.Cancers (Basel). 2021 Apr 1;13(7):1642. doi: 10.3390/cancers13071642. Cancers (Basel). 2021. PMID: 33915941 Free PMC article. Review.
-
LncRNA HOTAIR up-regulation is strongly related with lymph nodes metastasis and LAR subtype of Triple Negative Breast Cancer.J Cancer. 2019 May 12;10(9):2018-2024. doi: 10.7150/jca.29670. eCollection 2019. J Cancer. 2019. PMID: 31205562 Free PMC article.
-
Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients.Int J Mol Sci. 2017 Feb 21;18(2):459. doi: 10.3390/ijms18020459. Int J Mol Sci. 2017. PMID: 28230773 Free PMC article.
-
AXL Is a Novel Predictive Factor and Therapeutic _target for Radioactive Iodine Refractory Thyroid Cancer.Cancers (Basel). 2019 Jun 7;11(6):785. doi: 10.3390/cancers11060785. Cancers (Basel). 2019. PMID: 31181609 Free PMC article.
-
Interaction Proteomics Identifies ERbeta Association with Chromatin Repressive Complexes to Inhibit Cholesterol Biosynthesis and Exert An Oncosuppressive Role in Triple-negative Breast Cancer.Mol Cell Proteomics. 2020 Feb;19(2):245-260. doi: 10.1074/mcp.RA119.001817. Epub 2019 Dec 2. Mol Cell Proteomics. 2020. PMID: 31792072 Free PMC article.
References
-
- Elsamany S, Abdullah S. Triple-negative breast cancer: future prospects in diagnosis and management. Med Oncol. 2014;31:834. - PubMed
-
- Choi JE, Kang SH, Lee SJ, Bae YK. Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer. Ann Surg Oncol. 2015;22:82–89. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials